Jeremy Hunt must scrap a “pernicious” tax on share trading to breathe life back into the beleaguered London Stock Exchange after a drop-off in new listings, a top investment bank …
Personal Finance
London airports Luton and Stansted cash in as travel demand holds
London Luton and Stansted Airport are cashing on strong travel demand in early 2024, despite fears of a slowdown following last year’s post-Covid bounceback. Stansted Airport reported record breaking numbers …
Pay growth to ease for first time since Covid in ‘key moment for labour market’
Wage growth is set to slow in 2024 with employers planning to offer workers smaller pay rises than last year, a new survey suggests. Employers expect pay to increase by …
Hipgnosis independent valuer exits amid catalogue dispute
Hipgnosis Songs Fund’s independent valuer has exited its role amid a heated dispute over the valuation of the music fund’s catalogues, which include hits by Mariah Carey and The Rolling …
Fashion brand Lands’ End pins growth hopes on ‘renewed strategic focus’ after losses widen
The UK arm of US fashion brand Lands’ End is hoping a “renewed strategic focus” will help it return to growth in the coming years. The company, which has its …
Shawbrook owners mulling second listing attempt in potential boost for City
The owners of Shawbrook Bank are reportedly exploring another IPO for the lender after plans for a £2bn blockbuster listing fell through two years ago. Private equity firms BC Partners …
Yodel suitor The Delivery Group hails ‘strong’ performance despite ‘challenging’ year
Losses widened at The Delivery Group, which is among the companies who could be able to take over Yodel, during its latest financial year. According to newly-filed accounts, the business …
Heathrow: Britain has ‘shut the door’ on home-grown growth with tourist tax
Europe’s largest airport, Heathrow, has warned that Britain has “shut the door” on home grown growth by abolishing VAT-free shopping for overseas visitors. The west London hub’s officials made the …
GSK receives Fast Track designation for chronic hepatitis B drug in lastest boost for pharma giant
Pharmaceutical giant GSK has received special recognition from the US Food and Drug Administration (FDA) for its bepirovirsen drug, used to treat chronic hepatitis B (CHB). This recognition, called the …
Malvern International revenue rises on strong student intake but expects revenue hit from changes to immigration rules
Shares in education company Malvern International jumped 12 per cent on Monday morning after it reported a 79 per cent rise in revenue for its full year after it saw …